Sign in

NCT07066046Recruiting

Artificial Intelligence-assisted Colonoscopy in the Detection and Characterization of Colorectal Lesions

Artificial Intelligence-assisted Colonoscopy in the Detection and Characterization of Colorectal Lesions: Randomized Controlled Clinical Trial

Source: ClinicalTrials.gov · Last updated 23 Jun 2026

Brief summary (registry, in English)

The study aims to evaluate the effectiveness of artificial intelligence-assisted colonoscopy in increasing adenoma detection rate and the accuracy in the characterization of colorectal lesions, compared to standard colonoscopy, in a randomized controlled clinical trial setting.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
1000 (estimated)
First submitted
22 May 2025
Start date
1 Feb 2025
Primary completion date
1 Dec 2026
Lead sponsor
Instituto do Cancer do Estado de São Paulo
NCT number
NCT07066046

What you commit to

  • Study type: Interventional
  • Planned participants: 1000
  • From 1 Feb 2025 to the primary completion date, 1 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of inflammatory bowel disease.
  • History of colorectal cancer.
  • Personal history of colorectal surgery.
  • History of intestinal polyposis syndromes.

Other

  • Contraindication to endoscopic biopsies.
  • Urgent or emergency cases.
  • Presence of severe, decompensated comorbidities, or with a score of 3 or higher according to the American Society of Anesthesiologists (ASA) classification.
  • Incomplete colonoscopy that does not reach the cecum.
  • Insufficient or inadequate bowel preparation, with a score lower than 6 on the Boston Bowel Preparation Scale.
  • Patients who do not agree to participate in the study and do not sign the informed consent form (ICF).

Who the study is looking for

  • All patients aged 18 years or older, with an elective indication for colonoscopy who sign the informed consent form agreeing to participate in the study.

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Hospital das Clinicas da Faculdade de Medicina da USP
Coordinator of this site? Confirm its status
São PauloBrazilRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.